key: cord-0896446-lkuuftno authors: Beydon, N.; Gochicoa, L.; Jones, M.J.; Lands, L.C.; Lombardi, E.; Rosenfeld, M.; Sly, P.D.; Weiner, D.J.; Yilmaz, O. title: Lung function testing during a pandemic: an international perspective date: 2020-10-11 journal: Paediatr Respir Rev DOI: 10.1016/j.prrv.2020.10.001 sha: 8851c5da0c6cd0fc18a679d0ffe5218286954d87 doc_id: 896446 cord_uid: lkuuftno The COVID pandemic has passed its first peak for now in many countries while some are still on the rise, with some facing a second wave of cases. Precautions and infection control measures for both pediatric and adult pulmonary function testing (PFT) have been a topic of debate during the pandemic. Many centers had to close their PFT laboratories during the initial periods of the pandemic and are reopening as the numbers of new cases are decreasing. This review aims to summarize different practices of PFT laboratory management in different countries, including patient appointments, personal protective equipment, testing room requirements and telemedicine during and immediately following the COVID pandemic. The World Health Organization reported nearly 13 million cases of COVID-19 worldwide as of July, 2020 (1) . Children constitute a small proportion of people diagnosed with COVID-19 and generally have a more benign disease and course compared to adults (2) (3) (4) . The main features in children have been fever, cough and the diagnosis of pneumonia (2) . Considering that there is a possibility of disease transmission to the patients and staff from asymptomatic carriers, precautions for pulmonary function testing (PFT) laboratories have been controversial (5) . Many professional societies have published recommendations for precautions during PFT (6) (7) (8) (9) . These include postponing testing in non-urgent cases, personal protective equipment (PPE) for the respiratory technicians and PFT lab room characteristics such as negative pressure and adequate ventilation, HEPA filters, extensive hygiene measures and social distancing (6) (7) (8) (9) . Moreover, PFT must be avoided in suspected or confirmed COVID-19 cases (7) . Pediatric PFT labs have been closed during the pandemic in most hospitals except for emergency cases but are reopening in countries with a decrease in the number of cases. This review summarizes the international practice in different centers around the world aiming to emphasize similarities and differences in regional barriers and opportunities. Preparations before PFT concern two populations in pediatric care: the parents and the children. In most hospitals, families are screened with questionnaires about cough, shortness of breath, fever, loss of taste or smell, unusual fatigue or rhinitis/sinusitis and exposure to patients with COVID-19. If symptoms suggestive of COVID are reported, the test is re-scheduled until the results of COVID testing is available. The number of patients that can be seen has decreased in all centers owing to the increased time between tests required for adequate decontamination and air exchanges. The patients are usually scheduled with no overlap to avoid congregation in 6 6 the waiting area. Moreover, only one person is allowed to accompany the child when he or she presents for the appointment. Patients and visitors to the hospital are questioned about symptoms and contact on arrival, and in many hospitals no-contact temperature is measured at the hospital entrance. Some centers prescreen patients by phone within 48 hours prior to appointments. At some centers, a negative COVID test is required within 72 hours before performing PFTs. Patients and visitors are expected to have a face mask/covering to enter the hospital. Moreover, they are asked to use hand sanitizer. Face masks are required for patients and families except for children younger than 6 years (note some places under 10, some under 12 years of age). In some hospitals patients that arrive for a scheduled PFT are taken directly into the room where testing will be performed. In hospitals where waiting rooms are large enough to organize seats in compliance with social distancing rules or where environmental conditions allow waiting out of the hospital, overlapping of appointments is not a major problem, but the waiting room and door handles still need to be disinfected several times a day. In areas where climate allows waiting outside the hospital, patients may wait in an outdoor area. In hospitals with negative pressure PFT labs with 8 to 11 air exchanges per hour, urgent PFTs, that cannot be postponed despite COVID suspicion, are performed with the lab personnel wearing full COVID personal protective equipment (PPE). The testing room: Every hospital has different environment conditions that influence the PFT practice. The number of air exchanges determines how quickly aerosol droplets are removed from the environment. With negative pressure rooms providing 8 to 11 air exchanges per hour 7 7 or rooms equipped with portable or integrated HEPA filters, a delay is not required between patients. This may not be feasible in all hospitals; at some centers, PFTs are performed in rooms with windows that open outside. If these conditions do not exist, then there should be a 30minute waiting time between patients. Other measures include:, continuous air purifying respiratory (CAPRs) use, adding a plexiglass (Perspex) divider between the patient and therapist ( Table 1 ). All surfaces in the testing room such as the equipment, chairs, tables and plexiglass are wiped down with sanitizers after each patient. The testing equipment: Mouthpiece filters with bacterial and viral filtration efficiency of >99% are used for all measurements so the flow sensors do not need to be changed nor cleaned between patients. Procedures and aerosol generation: There has been a lot of debate regarding which procedures are aerosol generating; and while tidal breathing tests such as oscillometry or Rint and plethysmography are considered as not being aerosol generating, maneuvers that induce cough, including spirometry and bronchial provocation tests, are more likely to generate aerosols. Methacholine challenge testing may not be undertaken in many centers since it typically induces cough and requires nebulization. Exercise testing is another challenging PFT during the pandemic period since it results in high minute ventilation and may induce cough. Moreover, there is concern that filters may cause resistance during the high minute ventilation with exercise. Testing order: Independent of the epidemic, tidal breathing tests are done before forced expiration maneuver to prevent changes in static volumes and bronchial caliber. Therefore, during the pandemic tidal breathing tests such as Functional residual capacity (FRC) dilution, resistance, Tlco rebreathing are performed first, followed by slow expiration and inspiration tests such as FeNO, nasal NO, slow vital capacity (SVC), static volumes, TlcoBH, Pmax and Sniff nasal inspiratory pressure (Snip). Finally, forced expiration and exercise tests are 8 8 performed. The main idea is to have more aerosol generating tests, such as inducing sputum, performed after less aerosol generating tests, such as tidal breathing PFTs, in most centers, in order to leave the testing room right after the completion of the former. Testing personnel: Respiratory therapists or nurses performing all types of pulmonary function testing are screened daily for COVID symptoms by questionnaires and by temperature measurement in many centers. Moreover, home isolation if symptoms of fever, coryza and, cough develop and PCR testing is mandatory in some institutions. Respiratory therapists or nurses performing forced expiration techniques such as spirometry, DLCO and FeNO are required to wear a mask; in some centers or situations, this mask must be a FFP2 (equivalent of N95) mask. Otherwise, in all situations wearing gowns, gloves and face shield or goggles for testing is required in most hospitals. Moreover, testing that is likely to cause cough such as bronchial challenge and testing that leads to high minute ventilation such as exercise testing require full protective measures. (Table 1) . The indications for PFT in children do not change with the pandemic as stated in previous guidelines (10) . However, the risk to other patients and staff must be carefully weighed against the benefits to the patient. 9 9 In many hospital settings the indications for performing PFTs have been narrowed to include only the cases where diagnosis or acute management will change with the results of the PFT. Patients with cystic fibrosis are amongst the most commonly tested in the pediatric pulmonology departments. These patients and their families are already quite familiar with infection control measures such as wearing a mask and practicing social distancing. The decision to perform PFTs in these patients is evaluated on individual basis. While spirometry may be very valuable in guiding treatment, most clinics are postponing plethysmography, cardiopulmonary exercise testing and six-minute walk test in these patients. Home spirometry is a potentially promising alternative to office/clinic spirometry that can avoid the need for office/clinic visits and allow for more frequent monitoring. There has been rapid uptake of home spirometry in some regions and innovations are accelerating. However, there are still a number of unknowns that must be acknowledged, including accuracy, repeatability, clinical significance of acute declines, need for coaching and long-term patient adherence (11, 12) . Home spirometry use for specific populations may be an alternative for selected populations such as the asthmatics in the long term but it will require training of the subjects to fulfill the standards. The COVID-19 pandemic has also impacted scientific research that requires PFT as part of the protocol. Many researchers postponed PFT measurements in the study population without clinical indications. This will be a major limitation for ongoing research in addition to the cancellation of in-person visits for these subjects. In conclusion, PFT laboratories are re-opening in areas of the world where there is decreased number of new COVID-19 cases; but generally, with reduced activity at the 10 10 beginning. As experience and confidence with operating under restrictions is gained, activity increases. If there is a local increase of the case numbers, it is always possible to decrease the activity in an attempt to decrease contact. However, in the long term, it is probable that some changes implemented in the PFT labs during this pandemic will stay in daily practice even with no or low virus circulation ( Table 2) . The pandemic has necessitated reorganization of the pediatric pulmonary function testing (PFT) laboratories and practice. Future research on the extent of aerosol generation during various PFT techniques is needed for meticulous protection of the patients and health care personnel performing the procedure. Moreover, research to improve implementation of telemedicine in patient care will be important. WHO Coronavirus Situation Report-166 SARS-CoV-2 Infection in Children Clinical characteristics of COVID-19 in children compared with adults in Shandong Province COVID-19 epidemic: Disease characteristics in children COVID-19 transmission through asymptomatic carriers is a challenge to containment. Version 2. Influenza Other Respir Viruses Pulmonary Function Laboratories: Advice Regarding COVID-19 Italian pediatric respiratory society recommendations on pediatric pulmonary function testing during COVID-19 pandemic. Version 2 1 (Respiratory function technologists /Scientists)Lung function testing during COVID-19 pandemic and beyond Functional respiratory evaluation in the COVID-19 Era: The role of pulmonary function test laboratories Delivery of high-quality pediatric spirometry in rural communities: A novel use for telemedicine Discrepancy between Lung Function Measurements at Home and in the Hospital in Children with Asthma and CF This report was based on the webinar recorded by the American Thoracic Society Pediatric Assembly Virtual International Pediatric Pulmonology Network (https://vippn.thoracic.org) and European Respiratory Society. The opinions expressed are those of the authors, and do not represent official respiratory society opinions. All authors contributed equally so all need to be credited as first authors.